Form 8-K - Current report:
SEC Accession No. 0001213900-25-090129
Filing Date
2025-09-22
Accepted
2025-09-22 16:26:04
Documents
19
Period of Report
2025-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0257865-8k_oruka.htm   iXBRL 8-K 37156
2 FORM OF PRE-FUNDED WARRANT ea025786501ex4-1_oruka.htm EX-4.1 90658
3 SECURITIES PURCHASE AGREEMENT, DATED SEPTEMBER 17, 2025, BY AND BETWEEN ORUKA TH ea025786501ex10-1_oruka.htm EX-10.1 228370
4 FORM OF REGISTRATION RIGHTS AGREEMENT ea025786501ex10-2_oruka.htm EX-10.2 96647
5 PRESS RELEASE, DATED SEPTEMBER 17, 2025 ea025786501ex99-1_oruka.htm EX-99.1 13353
6 PRESS RELEASE, DATED SEPTEMBER 17, 2025 ea025786501ex99-2_oruka.htm EX-99.2 23481
10 GRAPHIC ex99-1_001.jpg GRAPHIC 6879
11 GRAPHIC ex99-2_001.jpg GRAPHIC 6879
  Complete submission text file 0001213900-25-090129.txt   798523

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE orka-20250917.xsd EX-101.SCH 3011
8 XBRL LABEL FILE orka-20250917_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE orka-20250917_pre.xml EX-101.PRE 22356
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0257865-8k_oruka_htm.xml XML 3678
Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 251330397
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)